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OsteoporosisOsteoporotic hip fractures cause high mortality in the elderly population. However, few population studies
reported the long-term mortality of hip fracture among the elderly in Asian population. This study assessed
the incidence, excess mortality, and risk factors after osteoporotic hip fractures through inpatients aged
60 years or older.
A total of 143,595 patients with hip fracture were selected from Taiwan National Health Insurance database
in the years 1999 to 2009 and followed up until the end of 2010. Annual incidence, mortality and SMR, and
mortality and SMR at different periods after fracture were measured.
From 1999 to 2005, hip fracture incidence gradually increased and then ﬂuctuated after 2006. From 1999 to
2009, the male-to-female ratio of annual incidence increased from 0.60 to 0.66, annual mortality for hip frac-
ture decreased from 18.10% to 13.98%, male-to-female ratio of annual mortality increased from 1.38 to 1.64,
and annual SMR decreased from 13.80 to 2.98. Follow-up SMR at one, two, ﬁve, and ten years post-fracture
was 9.67, 5.28, 3.31, and 2.89, respectively. Females had higher follow-up SMR in the younger age groups
(60–69 yr of age) but lower follow-up SMR in the older age groups (over 80 yr of age) compared with males.
Among the studied patients, incidence is gradually decreasing along with annual mortality and SMR. Hip
fracture affects short-term but not long-term mortality.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Osteoporotic hip fractures cause high mortality and adverse out-
comes in the elderly population [1–15]. Previous studies reported
that subjects who survived after hip fracture exhibited decreased mo-
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Inc. Open access under CC BY-NC-NDrequirement for care givers and social services, as well as consider-
able physical, mental, and ﬁnancial burden [7,9,15–20].
Previous studies estimated the annual number of hip fractures
to reach up to 2.6 million to 4.6 million by 2025 and 4.5 million
to 6.26 million by 2050 worldwide, with Asia and Latin America
exhibiting the greatest increase [21,22]. The Taiwanese population
increased from 15,927,167 in 1964 to 23,224,912 in 2011, and the
proportion of the elderly population aged 65 years or older increased
from 3% in 1964 to 10.7% in 2011 [23]. As the elderly population
increases rapidly in Taiwan, hip fractures will become an important
public health issue.
Several studies recently conﬁrmed the association between hip
fracture and mortality [4,8,9,24–29], with some exploring this associ-
ation using nationwide, long-term, follow-up population data from
Asia [9,25,27,28]. However, no population study reported on the ex-
cess mortality of hip fractures in Taiwan. Therefore, this study aims
to assess the incidence and excess mortality among hip fracture
patients through inpatients aged 60 years or older from a nationwide
population database in Taiwan. license.
Table 1
Baseline characteristics of subjects with a hip fracture by gender.
Total
(N = 143,595)
Male
(N = 56,403)
Female
(N = 87,192)
Age, mean ± SD (years) 78.13 ± 7.86 77.64 ± 7.73 78.65 ± 7.92
Hip fracture, N(%)
Cervical fracture 69,882 (48.67) 24,758 (43.89) 45,124 (51.75)
Trochanteric fracture 73,713 (51.33) 31,645 (56.11) 42,068 (48.25)
Operation type, N(%)
Internal ﬁxation 85,438 (59.50) 36,437 (64.60) 49,001 (56.20)
Hemiarthroplasty 58,157 (40.50) 19,966 (35.40) 19,966 (35.40)
CCI number, N(%)
0 58,217 (40.54) 20,153 (37.33) 37,164 (42.62)
1 38,218 (26.62) 14,772 (26.19) 23,446 (26.89)
2 23,560 (16.41) 9,904 (17.56) 13,656 (15.66)
3 13,032 (9.08) 5,748 (10.19) 7,284 (8.35)
≥4 10,568 (7.36) 4,926 (8.73) 5,642 (6.73)
CCI: Charlson Comorbidity Index.
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Data source and subjects
The National Health Insurance (NHI) database covers the period
between 1997 to the present, with data provided annually by the
Department of Health of Taiwan. The database covers all patients'
medical beneﬁt claims for more than 23 million Taiwanese residents
in 2011, with a coverage rate exceeding 99% of the whole population.
The completeness and accuracy of the NHI database is guaranteed by
the Department of Health and the NHI Bureau of Taiwan.
This study selected subjects aged 60 years or older, who were ad-
mitted to hospitals between 1 January 1999 and 31 December 2009.
Subjects were identiﬁed from the database based on the following
criteria: (i) a ﬁrst discharge diagnosis code of hip fracture (based on
International Classiﬁcation of Disease, Ninth Revision, Clinical Modiﬁ-
cation (ICD-9-CM) codes 820, 820.0, 820.00, 820.01, 820.02, 820.09,
820.8, 820.03, 820.2, 820.20, and 820.21) and (ii) medical code with
surgery of internal ﬁxation or hemiarthroplasty (based on ICD-9-CM
codes 79.15, 79.35, 81.52). The ﬁrst admission date of hip fracture
was deﬁned as the index date. The exclusion criteria were inpatients
with pathological fractures (ICD-9-CM codes 733.14 and 733.15),
open hip fractures (ICD-9-CM codes 820.1, 820.10, 820.11, 820.12,
820.19, 820.9, 820.13, 820.22, 820.3, 820.30, 820.31, and 820.32), or
involved in a major trafﬁc accident. Patients who had operations on
the pelvis, femur, and hip regions before the index date were exclud-
ed to avoid confounding effects. In total, 143,595 subjects with hip
fracture were enrolled in the study and followed up until exiting
the NHI program, death, or the end of 2010. The completeness and ac-
curacy of the NHI database is guaranteed by the Department of Health
and the NHI Bureau of Taiwan. Fracture diagnoses were based on
ICD-9 CM Code. On a regular basis, the NHI Bureau randomly assigned
senior orthopedic surgeons to inspect the original contents of pa-
tients' charts and ICD-9 CM Code to ensure the validity of ICD-9 CM
Code. The inspectors do not have any conﬂict of interest with the pa-
tients' hospitals. For these reasons, we infer that the validity of
fracture diagnoses is very high.
Outcome measures
This study analyzed two outcomes: (a) annual mortality and stan-
dardized mortality ratio (SMR) after hip fractures; as well as (b) mor-
tality and SMR at different time periods after hip fractures, and the
effects of risk factors on survival. Time to death was deﬁned as the
duration from the index date to death. Subjects alive or lost to follow
up were treated as censored. The comorbidities of a subject were re-
trieved before or at the time of the index date based on the Charlson
Comorbidity Index (CCI) [30].
Statistical analysis
For each cohort year, we calculated the incidence as the number of
inpatients with hip fracture divided by the mid-population of that co-
hort year and stratiﬁed them by gender. We calculated the annual
mortality as the number of death divided by the number of newly-
diagnosed cases of that cohort year and stratiﬁed them by gender.
We calculated follow-up mortality and SMR at different time periods
(one-month to ten-year for mortality and one-year to ten-year
for SMR) after fracture, and stratiﬁed them by age and gender.
Follow-up mortality was estimated by using the Kaplan–Meier meth-
od. We compared hip fracture mortality with that of the general pop-
ulation using annual and follow-up SMR. SMR was estimated based
on the following deﬁnition: the number of deaths among inpatients
with hip fracture divided by the expected number of death cases
according to age-speciﬁc, sex-speciﬁc, and calendar-year-speciﬁc
death rates obtained from the Taiwan national death registry. Wecompared the effects of risk factors such as age, gender, type of hip
fracture, and number of comorbidities on survival using the
log-rank test. All analyses were performed using the SAS System (ver-
sion 9.2; SAS Institute, Cary, NC) and the Statistical Package for the
Social Sciences (version 10.0; SPSS Inc, Chicago, IL).Results
Between 1999 and 2009, 143,595 subjects were admitted for the
ﬁrst time with a primary diagnosis of hip fracture and underwent
an operation. Among these patients, 56,403 (39.28%) were male,
87,192 (60.72%) were female, 69,882 had cervical fracture, and
73,713 had trochanteric fracture (Table 1). The annual incidence
rate of hip fracture gradually increased from 405/100,000 to 471/
100,000 from 1999 to 2005 (Table 2). Incidence then dropped to
446/100,000 in 2006 and ﬂuctuated between 451/100,000 and 476/
100,000 after 2006. From 1999 to 2009, the male-to-female ratio of
annual incidence increased from 0.60 to 0.66, annual mortality rate
of hip fracture gradually decreased from 18.10% to 13.98%, and
male-to-female ratio of annual mortality increased from 1.38 to 1.64
(Table 2). We used SMR to compare indirectly the mortality of sub-
jects after hip fracture to that of the general population in Taiwan.
The overall annual SMR gradually decreased from 13.80 to 2.98
from 1999 to 2009 (Table 2).
The 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 5-year
and 10-year mortality rates were respectively 2.49%, 6.45%, 10.40%,
16.32%, 25.84%, 33.40%, 44.12%, and 53.50% for the whole cohort
(Table 3). Moreover, the 1-month, 3-month, 6-month, 1-year,
2-year, 3-year, 5-year, and 10-year mortality rates were respectively
3.30%, 8.44%, 13.33%, 20.67%, 31.56%, 39.69%, 50.60%, and 59.25%
for males and 1.96%, 5.17%, 8.51%, 13.50%, 22.15%, 29.33%, 39.92%,
and 49.78% for females (Table 3). Males always exhibited higher
mortality rates than females (Table 3, Fig. 1).
We also calculated short- to long-term follow-up SMRs to com-
pare indirectly the mortality of subjects after hip fracture to that of
the general population in Taiwan. The overall SMRs at 1-year,
2-year, 3-year, 5-year, and 10-year after hip fracture were 9.67,
5.28, 4.16, 3.31 and 2.89, respectively (Table 4). The overall SMR
was higher at the ﬁrst year after fracture, dropped at the second
year, and decreased slowly after the second year to the 10th year
after fracture. We also calculated gender-by-age stratiﬁed SMRs,
which showed that females had a higher SMR in the younger age
groups (60 years to 69 years) but lower SMR in the older age groups
(greater than or equal to 80 years) compared with males. Overall, the
youngest female age group (60 years to 64 years) had the highest
SMRs (SMR of 34.75 at the ﬁrst year and SMR of 4.38 at the tenth
year) (Table 4).
Table 2
Annual incidence, mortality, and SMR of hip fracture in Taiwan.
Incidencea Mortalityb SMRc
Overall Male Female Ratiod Overall Male Female Ratiod Overall Male Female Ratiod
1999 405 308 510 0.60 18.10 21.70 15.73 1.38 13.80 14.38 13.44 1.07
2000 426 324 536 0.60 18.05 21.55 15.79 1.36 13.38 14.08 12.92 1.09
2001 428 330 530 0.62 18.19 22.50 15.37 1.46 12.78 13.71 12.16 1.13
2002 442 351 536 0.65 18.22 22.75 15.15 1.50 11.86 12.90 11.20 1.15
2003 444 345 545 0.63 17.00 20.86 14.51 1.44 10.87 11.60 10.35 1.12
2004 453 360 546 0.66 16.61 20.78 13.83 1.50 9.35 10.33 8.67 1.19
2005 471 373 567 0.66 15.67 20.73 12.37 1.68 8.37 9.42 7.64 1.23
2006 446 356 533 0.67 15.16 19.99 12.04 1.66 6.93 7.85 6.30 1.25
2007 476 378 571 0.66 14.86 18.83 12.31 1.53 5.30 6.23 4.67 1.33
2008 451 354 542 0.65 15.33 20.36 12.21 1.67 3.35 3.96 2.91 1.36
2009 463 367 554 0.66 13.98 18.41 11.21 1.64 2.98 3.58 2.75 1.30
a Annual incidence = 100000 ∗ the number of new cases/the number of population in that calendar year.
b Annual mortality = the number of death/the number of new cases.
c Annual SMR were calculated from the date of ﬁrst diagnosed as hip fracture in that calendar year and followed up to one year, detailed formula as deﬁned in the Methods
section.
d Ratio: male/female.
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ture, and the value of CCI is shown in Fig. 1. Statistically signiﬁcant
risk factors of overall death were male, older age, trochanteric frac-
ture, and a large value of number of CCI.
Discussion
Ours is the ﬁrst population study that reported on the excess mor-
tality of subjects after hip fracture in Taiwan. The annual mortality of
subjects after hip fracture decreased gradually during the study peri-
od. The annual SMR decreased gradually from 1999 to 2003 and de-
clined pronouncedly from 2004 to 2009. This may be accounted forTable 3
One-month to 10-year cumulative mortality stratiﬁed by gender and age.
Mortality rate (%)
1-M 3-M 6-M 1-year 2-year 3-year 4
Overall
Total 2.49 6.45 10.40 16.32 25.84 33.40 3
Male 3.30 8.44 13.33 20.67 31.56 39.69 4
Female 1.96 5.17 8.51 13.50 22.15 29.33 3
60–64
Total 0.87 2.65 4.70 7.72 12.65 16.81 2
Male 1.01 3.05 5.15 8.51 14.43 19.52 2
Female 0.76 2.31 4.34 7.05 11.16 14.54 1
65–69
Total 1.31 3.76 6.32 10.08 16.96 22.22 2
Male 1.71 4.42 7.35 12.08 20.52 26.76 3
Female 1.04 3.31 5.63 8.74 14.56 19.16 2
70–74
Total 1.57 4.41 7.41 12.08 19.76 26.15 3
Male 1.94 5.37 8.90 14.89 24.72 32.19 3
Female 1.30 3.72 6.35 10.08 16.22 21.84 2
75–79
Total 2.15 5.72 9.41 14.94 23.81 31.10 3
Male 3.01 7.63 12.36 19.50 29.76 37.98 4
Female 1.54 4.37 7.33 11.72 19.60 26.22 3
80–84
Total 2.72 7.18 11.49 18.32 29.08 37.26 4
Male 4.09 10.27 16.01 24.82 37.11 45.98 5
Female 1.88 5.28 8.71 14.32 24.14 31.91 3
≥85
Total 4.44 10.66 16.55 24.89 38.01 48.29 5
Male 5.96 15.00 22.72 33.06 47.55 57.64 6
Female 3.66 8.44 13.39 20.71 33.14 43.51 5
Estimated by using the Kaplan–Meier method.by the launch of the national insurance program in 1995, which
improved the health care services that were available in Taiwan.
This general improvement in health care, as well as the year-by-
year improvement to surgical techniques, explains the decrease in
peri-operative mortality and short-term post-operative mortality
prior to 2002/2003. The rapid decline in mortality for hip fracture
patients after 2002/2003 may be due to the fact that Taiwan's health
insurance program began using a case payment system on a wide
scale in 2002, which allowed for better funding for hip fracture pa-
tients and more complete care to be provided. The general population
also had a decrease in mortality, but it did not decrease as sharply as
mortality among hip fracture patients. This is because hip fracture-year 5-year 6-year 7-year 8-year 9-year 10-year
9.49 44.12 47.61 50.11 51.74 52.85 53.50
5.99 50.60 53.91 56.26 57.68 58.66 59.25
5.29 39.92 43.53 46.12 47.89 49.09 49.78
0.60 23.50 25.93 27.87 29.16 30.24 31.05
3.98 27.00 29.71 31.80 33.18 34.32 35.36
7.76 20.56 22.77 24.57 25.79 26.81 27.43
6.22 29.77 32.85 35.35 36.94 38.25 39.16
1.07 34.80 38.20 41.00 42.69 44.06 45.02
2.96 26.37 29.23 31.54 33.06 34.33 35.20
1.64 35.86 39.28 42.01 43.92 45.34 46.14
8.76 43.42 47.13 50.33 52.35 53.72 54.48
6.56 30.47 33.68 36.07 37.91 39.36 40.20
7.26 42.17 45.80 48.45 50.24 51.44 52.17
4.60 49.72 53.55 55.97 57.47 58.56 59.17
2.06 36.82 40.31 43.13 45.13 46.39 47.21
4.11 49.21 53.04 55.62 57.32 58.45 59.02
2.87 58.11 61.11 63.27 64.48 65.26 65.64
8.72 43.74 48.07 50.93 52.91 54.26 54.96
5.70 60.84 64.39 66.56 67.82 68.46 68.81
4.37 68.56 71.31 72.74 73.50 73.87 74.13
1.28 56.89 60.86 63.40 64.91 65.69 66.10
(a) (b)
(c) (d)
log-rank p<0.0001
log-rank p<0.0001
log-rank p<0.0001
log-rank p<0.0001
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.0
0.1
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.0
0.1
0 2 4 6 8 10
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.0
0.1
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.0
0.1
0 2 4 6 8 10
0 2 4 6 8 100 2 4 6 8 10
Female
Male
60-64
65-69
70-74
75-79
80-84
>85
> 4
Cervical
Trochanteric 0
1
2
3
Cu
m
ul
at
iv
e 
su
rv
iv
al
Cu
m
ul
at
iv
e 
su
rv
iv
al
Cu
m
ul
at
iv
e 
su
rv
iv
al
Cu
m
ul
at
iv
e 
su
rv
iv
al
Year
Year
Year
Year
Fig. 1. Ten-year overall survival curves by (a) gender, (b) age group, (c) fracture type, and (d) CCI number.
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population did not require health care services. Therefore, the general
population mortality rate would not be impacted by the nationalTable 4
One- to 10-year follow-up SMR stratiﬁed by gender and age.
SMR
1-yeara 2-yearb 3-year 4-year 5-yea
Overall
Total 9.67 5.28 4.16 3.61 3.31
Male 10.44 5.81 4.62 4.03 3.71
Female 9.15 4.94 3.86 3.35 3.07
60–64
Total 28.05 13.95 9.91 7.88 6.71
Male 23.81 11.95 8.60 6.86 5.87
Female 34.75 17.05 11.88 9.39 7.92
65–69
Total 23.54 11.82 8.48 6.82 5.83
Male 20.51 10.44 7.59 6.14 5.28
Female 26.99 13.33 9.43 7.54 6.40
70–74
Total 17.32 8.81 6.38 5.17 4.47
Male 16.39 8.47 6.20 5.06 4.40
Female 18.32 9.16 6.57 5.28 4.53
75–79
Total 12.52 6.50 4.86 4.06 3.60
Male 12.08 6.42 4.87 4.13 3.72
Female 12.93 6.57 4.85 4.00 3.51
80–84
Total 8.66 4.58 3.50 2.97 2.70
Male 8.91 4.91 3.88 3.38 3.15
Female 8.49 4.36 3.27 2.75 2.47
≥85
Total 6.04 3.55 3.00 2.77 2.69
Male 6.80 4.11 3.56 3.33 3.25
Female 5.67 3.29 2.75 2.54 2.47
a Death within 1 year after fracture.
b Death between ﬁrst year and second year after fracture.insurance program as heavily as the peri-operative mortality and
short-term postoperative mortality. The estimated 1-year, 2-year,
3-year, 5-year, and 10-year follow-up mortalities were 16.32, 25.84,r 6-year 7-year 8-year 9-year 10-year
3.15 3.05 2.98 2.94 2.89
3.51 3.39 3.31 3.24 3.17
2.92 2.85 2.79 2.75 2.72
5.83 5.21 4.71 4.27 3.94
5.13 4.60 4.26 3.83 3.61
6.82 6.04 5.31 4.86 4.38
5.20 4.73 4.35 4.07 3.85
4.74 4.29 3.94 3.68 3.52
5.67 5.17 4.77 4.48 4.19
4.04 3.72 3.51 3.34 3.21
3.99 3.70 3.53 3.37 3.23
4.09 3.74 3.48 3.30 3.19
3.34 3.15 3.03 2.94 2.87
3.49 3.35 3.25 3.17 3.11
3.21 3.01 2.88 2.79 2.71
2.57 2.53 2.52 2.54 2.54
3.01 2.97 2.97 2.99 2.96
2.34 2.31 2.30 2.32 2.34
2.66 2.68 2.68 2.69 2.68
3.20 3.19 3.18 3.20 3.15
2.45 2.48 2.49 2.51 2.50
151C.-B. Wang et al. / Bone 56 (2013) 147–15333.40, 44.12, and 53.50, respectively. Compared with the general pop-
ulation, the highest SMR occurred at the ﬁrst year after hip fracture
and then decreased gradually for follow-up from the second year up
to the 10th year after fracture. Gennaro et al. also reported very sim-
ilar ﬁndings [31]. Furthermore, we analyzed the causes of death strat-
iﬁed by year of death for up to ten years following the index day
(Appendix 1). We found that cancer, diabetes, cardiovascular disease,
cerebrovascular disease, renal disease and pneumonia were the major
causes, each of which is highly related to the aging process. Though
they ﬂuctuated slightly from year to year, overall each one's contribu-
tion to death remained stable. Furthermore, we calculated the
average age of death for every year and the results showed an in-
creased age of death in hip fracture patients (Appendix 4). We calcu-
lated the surgery type distribution every year and found that it
remained stable (Appendix 2). Finally, we calculated the prevalence
of comorbidities and found that Chronic Obstructive Pulmonary
Disease (18.2%), Cerebrovascular disease (20.4%), Diabetes mellitus
(24.1%) and peptic ulcer disease (10.1%) were most prevalent in the
hip fracture cohort (Appendix 3).
Secular trend of mortality
Annual mortality decreased gradually from 18.10% to 13.98%, where-
as annual SMR also decreased from13.80 to 2.98 during the study period.
This ﬁnding may be attributed to the improvement in medical care and
technology. The 1-month, 3-month, 6-month, 1-year, 2-year, 5-year,
and 10-year follow-up mortality rates were 2.49, 6.45, 10.40, 16.32,
25.84, 33.40, 44.12, and 53.50, respectively. The 1-month mortality was
2.49% in Taiwan, lower than that of England (9.6%), Scotland (7%), and
the US (8.9%, 5.2% to 9.3%) [10,32–34]. The 3-month mortality was
6.45% in Taiwan, lower than that of Norway (10%), Sweden (10%–20%),
and the US (17.5%) [26,33,35,36]. The 1-year mortality was 16.32% in
Taiwan, lower than that of Korea (17.8), Japan (19%), the US (16.9%,
12% to 32%), England (33%), Canada (30.8%), Denmark (29.2%), Finland
(27.3%), and Sweden (21% to 33%) [9,14,25,32,34,37–39]. Haleem et al.
reviewed published articles from 1996 to 1998 and found that mortality
at sixmonths and one yearwere 11% to 23% and 22% to 29%, respectively
[11]. Haentjens et al. performed a meta-analysis and found a ﬁvefold to
eightfold relative risk for death compared with the controls during the
ﬁrst three months after fracture [13]. Abrahamsen et al. also conducted
a meta-analysis for hip fracture mortality and estimated the crude mor-
tality rates for at one month, three months, six months, and one year as
3.3% to 17.2%, 6.4% to 20.4%, 7.1% to 23%, and 5.9% to 59%, respectively.
Abrahamsen et al. also found that the highest excess mortality was in
theﬁrst threemonths to sixmonths and that excessmortality decreased
after one year, but remained high for several years [12]. Hu et al. also
conducted a meta-analysis and found that the overall mortality for one
month, three months, one year, and two years was 13.3%, 15.8%, 24.5%,
and 34.5%, respectively [40]. Only a few studies reported on long-term
mortality rates. Lin et al. reported that the ﬁve-year mortality of 217
non-institutionalized patients was 42% from a tertiary medical center
in Taiwan [41]. Tusboi reported that the ﬁve-year and 10-year mortality
of 1169 patients were respectively 51% and 74% from 74 hospitals afﬁli-
ated with Nagoya University in Japan [9]. Von Friesendorff reported that
mortalitywas 52% atﬁve years and 77% at 10 years forwomenbut 64% at
ﬁve years and 81% at 10 years for men [35,36]. Possible factors that con-
tributed to the differences among regions included different selection
criteria, distributions of age-gender stratiﬁed population, smoking, phys-
ical activity, nutrition, bone mineral density, shorter hip axis length, and
hip strength [42–44].
SMR and excess mortality
We used follow-up SMR to compare indirectly the mortality of
subjects after hip fracture with that of the general population. The
overall follow-up SMRs at 1-year, 2-year, 5-year, and 10-year were9.67, 5.28, 3.31, and 2.89, respectively. We found that subjects with
hip fractures had higher SMR than the general population in Taiwan.
Overall, SMR at the ﬁrst year after fracture was the highest, and that
at two to 10 years after fracture decreased gradually. Age-speciﬁc
SMR continuously decreased at ﬁve to 10 years after fracture for sub-
jects aged 60 years to 79 years. However, SMR remained similar at 5
to 10 years after fracture for subjects aged greater than 80 years. This
ﬁnding indicates that hip fracture signiﬁcantly affects short-term
mortality on the ﬁrst year after hip fracture. Our ﬁnding is similar to
that of several individual and meta-analysis studies, which reported
that hip fractures affect short-term but not long-term mortality
[1,8,12,13,24,45]. A number of studies demonstrated that hip frac-
tures affect long-term mortality continuously even one year after
fracture [2–6,9,26], which is consistent with our results of twofold
to fourfold SMR at the tenth years after fracture. However, we believe
that the high ratio for the long-term period might be primarily attrib-
uted to the effect from the previous period, speciﬁcally the ﬁrst year
after hip fracture. We also found that SMR varied by gender and age
in Taiwan, as reported in the literature [14,25,37,46]. We found that
males had higher SMR than females when disregarding the age
effect. Taking age into consideration, our results showed that females
actually had higher SMR in the younger age groups (aged 60 to 69),
but lower SMR in the older age groups (greater than or equal to
80 years) when compared with males. Similar ﬁndings were also
found in Korea [25]. We suspect that the withdrawal effect of estro-
gen after menopause is more pronounced in the younger female
(aged 60–69) among Asian populations. But we have no data to sup-
port this speculation. Other studies from Finland, Denmark, and the
US found that males had higher SMR than females consistently for
all age groups [14,46].Limitations
Subjects with hip fracture as deﬁned in this work were elderly
inpatients with age equal to or greater than 60 years, who were
followed up at various periods (one to 12 years). Therefore, unknown
confounding factors might exist or change during the follow-up
period. Although we have conducted an analysis to examine a num-
ber of risk factors, many were not available for adjustment, such as
pre-operative joint function/condition, smoking status, body mass
index, bone mineral density, lifestyle, severity of comorbidity, and
quality of life, among others. Unlike other case–control or cohort
studies, we did not include controls. We calculated SMRs from the
national health statistics and did not directly compare the relative
risk of death to the population without hip fracture or to the popula-
tion who had hip fracture but did not undergo surgery. The main rea-
son is that we do not have the complete data on these populations in
the database to enable us to perform such an analysis.Conclusions
Between 1999 and 2009, the incidence rate of hip fracture in
Taiwan's elderly aged 60 years or older declined, as did annual mor-
tality and SMR. Comparing SMR with Taiwan's general population,
hip fracture mainly affected short-term mortality, especially in the
ﬁrst year following hip fracture (SMR = 9.67). Comparison of elderly
males and females by age group showed that female SMR was higher
thanmale SMR in the younger age group and vice versa in the older age
group. Age- and gender-speciﬁc intervention strategies are required for
osteoporotic hip fracture.Conﬂicts of interest
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Causes of death stratiﬁed by year of death after hip fracture.Cause of death (%)
1-year 2-year 3-year 4-year 5-year 6-year 7-year 8-year 9-year 10-year
Tuberculosis 1.0 0.9 0.9 0.9 0.8 0.8 0.8 0.8 0.8 0.8
Septicemia 1.8 1.9 1.9 1.9 2.0 2.1 2.1 2.1 2.2 2.2
Malignant 15.2 14.9 14.6 14.2 13.9 13.7 13.6 13.5 13.5 13.5
Diabetes 10.3 10.2 10.1 10.0 9.9 9.8 9.8 9.7 9.7 9.6
Heart disease 9.6 9.7 9.8 10.0 10.1 10.1 10.1 10.2 10.2 10.2
Hypertensive disease 2.3 2.4 2.4 2.4 2.4 2.5 2.5 2.5 2.5 2.5
Cerebrovascular diseases 7.7 8.8 9.3 9.5 9.7 9.8 9.9 9.9 9.9 9.9
Pneumonia 7.2 7.5 7.7 8.0 8.2 8.3 8.3 8.4 8.4 8.5
Bronchitis, emphysema and asthma 1.1 1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.1 1.1
Ulcers of the stomach and duodenum 1.1 1.0 0.9 0.8 0.8 0.8 0.8 0.7 0.7 0.7
Chronic liver disease and cirrhosis 2.1 1.9 1.8 1.7 1.6 1.6 1.5 1.5 1.5 1.5
Nephritis, nephrotic syndrome and nephrosis 7.3 7.0 7.1 7.1 7.0 6.9 6.9 6.9 6.8 6.8
Accidental injury 4.1 3.2 2.8 2.6 2.5 2.4 2.3 2.3 2.3 2.3
Suicide 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Chronic lower respiratory diseases 4.6 4.9 5.0 5.0 5.1 5.1 5.2 5.2 5.2 5.2
Aging/old 3.8 3.8 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9
Apnea 4.6 4.6 4.6 4.6 4.6 4.6 4.6 4.6 4.6 4.6
Gastrointestinal bleeding 1.4 1.3 1.2 1.2 1.1 1.1 1.1 1.1 1.1 1.0
Other 14.2 14.5 14.6 14.8 15.0 15.1 15.2 15.4 15.5 15.6Appendix 2
Changes of treatmentYear %
Internal ﬁxation Hemiarthroplasty
2000 60.4 39.7
2001 60.4 39.6
2002 60.0 40.0
2003 58.5 41.5
2004 59.5 40.5
2005 59.1 40.9
2006 59.2 40.8
2007 59.0 41.0
2008 58.4 41.6
2009 58.0 42.0
Death year Average age of death
2000 79.9
2001 80.5
2002 80.4
2003 80.9
2004 81.4
2005 81.7
2006 82.1
2007 82.4
2008 82.8
2009 82.9Appendix 3
Prevalence of Charlson ComorbidityCharlson comorbidity Prevalence (%)
Myocardial infraction 2.8
Congestive heart failure 8.8
Peripheral vascular disease 1.8
Cerebrovascular disease 20.4
Dementia 4.8
Chronic obstructive pulmonary disease 18.2
Connective tissue disease 0.9
Peptic ulcer disease 10.1
Mild liver disease 4.1
Diabetes mellitus 24.1
Hemiplegia 4.5
Moderate to severe renal disease 8.0
Diabetes mellitus with end organ damage 6.2
Primary cancer 6.9
Leukemia 0.1
Lymphoma 0.2
Moderate to severe liver disease 0.9
Metastatic solid tumor 1.7
AIDS 0.0Appendix 4
Average age of deathReferences
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